The partnership will integrate PhaseV's adaptive clinical trial technology with Alimentiv's comprehensive GI CRO services.

Guwahati researchers, in partnership with global institutions, have developed an adaptive multi-stage clinical trial method ...

Since the first, seminal randomised controlled trial (RCT) in inflammatory bowel disease (IBD) in 1955,1 the central tenets ...

Laurie Adami's experience with CAR T-cell therapy highlights its potential in treating Non-Hodgkin Lymphoma, emphasizing the ...

Gastrointestinal-focused CRO Alimentiv is upgrading its clinical trials with software firm PhaseV’s adaptive trial technology ...

PhaseV, a pioneer in software and machine learning (ML) for clinical trial optimization, announced today it has entered a ...

According to leading data and analytics company GlobalData’s Clinical Trials Database, over the past 20 years trial activity ...

In early phase trials innovative designs offer potential for improvements in efficiency and decision-making. Determining the ...